-transparent.png){kind=logo}
Miglitol is an alpha-glucosidase inhibitor which lowers blood glucose and insulin concentrations in healthy volunteers after a starch meal. It also lowers blood glucose concentrations after a starch meal in patients with non-insulin-dependent diabetes mellitus, but under these circumstances insulin is unaffected. We have studied the effect of miglitol after a glucose load in six healthy male volunteers. Although one would expect an alpha-glucosidase inhibitor to have no effect on blood glucose concentrations after a glucose load, miglitol produced a significant decrease in blood glucose concentrations after the absorption peak. This could be due to enhancement of insulin effects or to depression of anti-insulin factors.
P H Joubert, and
G N Foukaridis, and
M L Bopape
April 1992,
Diabetes care,
P H Joubert, and
G N Foukaridis, and
M L Bopape
November 1999,
Expert opinion on pharmacotherapy,
P H Joubert, and
G N Foukaridis, and
M L Bopape
January 1989,
European journal of clinical pharmacology,
P H Joubert, and
G N Foukaridis, and
M L Bopape
February 1989,
Diabetes research (Edinburgh, Scotland),
P H Joubert, and
G N Foukaridis, and
M L Bopape
March 2009,
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
P H Joubert, and
G N Foukaridis, and
M L Bopape
March 2006,
Nihon yakurigaku zasshi. Folia pharmacologica Japonica,
P H Joubert, and
G N Foukaridis, and
M L Bopape
June 1996,
Diabetes care,
P H Joubert, and
G N Foukaridis, and
M L Bopape
June 2004,
Bioorganic & medicinal chemistry letters,
P H Joubert, and
G N Foukaridis, and
M L Bopape
May 2000,
MMW Fortschritte der Medizin,
P H Joubert, and
G N Foukaridis, and
M L Bopape
January 2014,
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
